News & Analysis on Clinical Trial Services & Contract Research And Development
By Melissa Fassbender
- Last updated on
The contract research organization (CRO) has named industry executive John Cargill as its chief commercial officer.
Cargill has held executive roles at several CROs, most recently as vice president at Covance. In this role, he headed global business development for clinical analytics and strategic clinical sourcing.
Cargill told us, “In my new role, I will be responsible for Clinipace’s global business development and internal sales teams. I plan to leverage Clinipace’s team-oriented, personal approach and my experience in the biotech, life science and health care sectors to forge new relationships and strengthen existing ones across the industry.”